Talis Biomedical Corporation
TLIS · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$62,007 | -$113,012 | -$192,036 | -$91,130 |
| Dep. & Amort. | $770 | $8,830 | $1,578 | $763 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4,351 | $5,368 | $9,207 | $3,683 |
| Change in WC | -$3,424 | -$7,686 | $8,824 | -$951 |
| Other Non-Cash | $7,070 | $6,364 | $1,043 | $611 |
| Operating Cash Flow | -$53,240 | -$100,136 | -$171,384 | -$87,024 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$486 | -$1,615 | -$2,866 | -$8,201 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$486 | -$1,615 | -$2,866 | -$8,201 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $33 | $406 | $232,546 | $246,754 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $1,883 | $246,754 |
| Financing Cash Flow | $33 | $406 | $234,429 | $246,754 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$53,693 | -$101,345 | $60,179 | $151,529 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $131,967 | $233,312 | $173,133 | $21,604 |
| End Cash | $78,274 | $131,967 | $233,312 | $173,133 |
| Free Cash Flow | -$53,726 | -$101,751 | -$174,250 | -$95,225 |